EMPIRE BIO A/S: Financial statements 2012
CVR: 12627343
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
EMPIRE BIO A/S (CVR 12627343) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 7,728,370 and a net result of DKK 1,480,608. Equity in the 2012 report amounted to DKK 2,302,393. The solvency ratio was 24%.
- Gross Profit
- DKK 7,728,370
- Profit/Loss
- DKK 1,480,608
- Equity
- DKK 2,302,393
- Total Assets
- DKK 9,590,006
Official annual report
Keep an eye on EMPIRE BIO A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of February 23, 2012, Christer Öberg has joined the board of directors of EMPIRE BIO A/S.
As of February 23, 2012, Karl Peter Fornstam has joined the board of directors of EMPIRE BIO A/S.
As of February 23, 2012, Jan Lennart Mikael Bernhardsson has left the board of directors of EMPIRE BIO A/S.
About EMPIRE BIO A/S
EMPIRE BIO A/S is a Danish company of the type Aktieselskab based in København N, founded in 1988. The company is registered under the industry Fremvisning af film og andre billedmedier. The company was previously named EMPIRE STAGE BUILDING ApS and ApS KBUS 8 NR. 3654. The management consists of Mette Schramm. The board consists of Karl Peter Fornstam (chair), Claus Norreen, Karl Mikael Håland and Mette Schramm. The company's owners include DANNY RED HOLDING ApS, REEL PICTURES ApS and SR Holding af 2019 ApS. The company has 43 employees (2026). In 2025, the company reported a gross profit of DKK 6,676,804 and a net result of DKK -54,528 compared with DKK -326,674 the year before. Equity in the 2025 report amounted to DKK 4,178,551.